Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
17.55
+0.06 (0.31%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $2.20 billion as of April 25, 2025. Its market cap has decreased by -66.07% in one year.
Market Cap
2.20B
Enterprise Value
2.26B
1-Year Change
-66.07%
Ranking
Category
Stock Price
$17.55
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.20B, an increase of 218.57%. That is a compound annual growth rate of 16.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 766.88B |
| UnitedHealth Group | 387.72B |
| Johnson & Johnson | 369.52B |
| AbbVie | 318.61B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.49B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |